{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:28:28Z","timestamp":1791106108929,"version":"4.1.0"},"reference-count":270,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.neuroscience.2011.06.075","type":"journal-article","created":{"date-parts":[[2011,7,12]],"date-time":"2011-07-12T12:35:06Z","timestamp":1310474106000},"page":"165-184","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Functional interactions within striatal microcircuit in animal models of Huntington's disease"],"prefix":"10.1016","volume":"211","author":[{"given":"V.","family":"Ghiglieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bagetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Picconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2011.06.075_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/mds.870030411","article-title":"Somatosensory phenomena in Huntington's disease","volume":"3","author":"Albin","year":"1988","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM199005033221807","article-title":"Abnormalities of striatal projection neurons and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease","volume":"322","author":"Albin","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchemneu.2009.02.001","article-title":"Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease","volume":"37","author":"Allen","year":"2009","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib6","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1073\/pnas.74.9.3767","article-title":"3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase","volume":"74","author":"Alston","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","article-title":"Dopamine and glutamate in Huntington's disease: a balancing act","volume":"16","author":"Andre","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib8","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1152\/jn.01118.2005","article-title":"Altered cortical glutamate receptor function in the R6\/2 model of Huntington's disease","volume":"95","author":"Andre","year":"2006","journal-title":"J Neurophysiol"},{"issue":"Pt 12","key":"10.1016\/j.neuroscience.2011.06.075_bib9","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington's disease progression","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"issue":"Pt 6","key":"10.1016\/j.neuroscience.2011.06.075_bib10","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jnnp.38.7.669","article-title":"Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea","volume":"38","author":"Aquilonius","year":"1975","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jnr.10272","article-title":"Striatal neurochemical changes in transgenic models of Huntington's disease","volume":"68","author":"Ariano","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","article-title":"Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease\u2014an in situ hybridization study","volume":"56","author":"Arzberger","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/WNL.44.5.823","article-title":"Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons","volume":"44","author":"Aylward","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archneur.1996.00550120105023","article-title":"Basal ganglia volume and proximity to onset in presymptomatic Huntington disease","volume":"53","author":"Aylward","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P","article-title":"Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease","volume":"15","author":"Aylward","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and rate of striatal atrophy in preclinical Huntington disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology"},{"issue":"Pt 12","key":"10.1016\/j.neuroscience.2011.06.075_bib18","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"Backman","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib19","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1097\/00001756-199712010-00027","article-title":"BDNF enhances neuronal growth and synaptic activity in hippocampal cell cultures","volume":"8","author":"Bartrup","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2007.04.012","article-title":"Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes","volume":"27","author":"Battista","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib22","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1471-4159.1986.tb12976.x","article-title":"Somatostatin binding sites in human and monkey brain: localization and characterization","volume":"46","author":"Beal","year":"1986","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.neuroscience.2007.03.010","article-title":"Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease","volume":"147","author":"Benn","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/neu.20319","article-title":"Brain-derived neurotrophic factor selectively regulates dendritogenesis of parvalbumin-containing interneurons in the main olfactory bulb through the PLCgamma pathway","volume":"66","author":"Berghuis","year":"2006","journal-title":"J Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib26","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1460-9568.2004.03561.x","article-title":"Brain-derived neurotrophic factor controls functional differentiation and microcircuit formation of selectively isolated fast-spiking GABAergic interneurons","volume":"20","author":"Berghuis","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib27","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1523\/JNEUROSCI.17-17-06761.1997","article-title":"Dopaminergic neurons intrinsic to the primate striatum","volume":"17","author":"Betarbet","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0301-0082(98)00006-9","article-title":"Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach","volume":"55","author":"Bezard","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib29","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1523\/JNEUROSCI.16-17-05523.1996","article-title":"Expression of normal and mutant huntingtin in the developing brain","volume":"16","author":"Bhide","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib30","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/brain\/97.1.457","article-title":"Huntington's chorea","volume":"97","author":"Bird","year":"1974","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/acps.1980.61.s280.63","article-title":"Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness","volume":"280","author":"Bird","year":"1980","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib32a","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev.pa.20.040180.002533","article-title":"Chemical pathology of Huntington's disease","volume":"20","author":"Bird","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Blazquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.01.021","article-title":"Early exploratory behavior abnormalities in R6\/1 Huntington's disease transgenic mice","volume":"1005","author":"Bolivar","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib35","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1523\/JNEUROSCI.20-09-03221.2000","article-title":"Brain-derived neurotrophic factor differentially regulates excitatory and inhibitory synaptic transmission in hippocampal cultures","volume":"20","author":"Bolton","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/14656566.8.2.141","article-title":"A systematic review of the treatment studies in Huntington's disease since 1990","volume":"8","author":"Bonelli","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1101\/lm.82104","article-title":"Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons","volume":"11","author":"Bonsi","year":"2004","journal-title":"Learn Mem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib38","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","article-title":"Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies","volume":"63","author":"Borrell-Pages","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/01688638408401231","article-title":"Clinical correlates of dementia and disability in Huntington's disease","volume":"6","author":"Brandt","year":"1984","journal-title":"J Clin Neuropsychol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib41","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0306-4522(83)90138-0","article-title":"The electrophysiology of dopamine (D2) receptors: a study of the actions of dopamine on corticostriatal transmission","volume":"10","author":"Brown","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib44","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1073\/pnas.89.16.7403","article-title":"Somatotopic organization in rat striatum: evidence for a combinational map","volume":"89","author":"Brown","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0306-4522(94)00431-4","article-title":"Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease","volume":"64","author":"Burns","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archpsyc.1978.01770270127013","article-title":"Huntington's dementia","volume":"35","author":"Caine","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0166-2236(99)01501-5","article-title":"Acetylcholine-mediated modulation of striatal function","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib48","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1523\/JNEUROSCI.12-11-04224.1992","article-title":"Long-term synaptic depression in the striatum: physiological and pharmacological characterization","volume":"12","author":"Calabresi","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tins.2007.03.001","article-title":"Dopamine-mediated regulation of corticostriatal synaptic plasticity","volume":"30","author":"Calabresi","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0166-2236(96)81862-5","article-title":"The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia","volume":"19","author":"Calabresi","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib52","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1073\/pnas.1016190108","article-title":"Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease","volume":"108","author":"Cayzac","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib53","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/sj.npp.1300458","article-title":"A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic transmission","volume":"29","author":"Centonze","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib54","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1523\/JNEUROSCI.21-04-01393.2001","article-title":"Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation","volume":"21","author":"Centonze","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib55","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.biopsych.2005.03.008","article-title":"Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6\/2 Huntington's disease mice","volume":"57","author":"Centonze","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib57","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1073\/pnas.90.20.9576","article-title":"Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated","volume":"90","author":"Cepeda","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib58","doi-asserted-by":"crossref","first-page":"e00033","DOI":"10.1042\/AN20090058","article-title":"Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms","volume":"2","author":"Cepeda","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib59","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib60","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington's disease","volume":"23","author":"Cha","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib64","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib65","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymeth.2009.05.007","article-title":"Generation of transgenic monkeys with human inherited genetic disease","volume":"49","author":"Chang","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2007.07.028","article-title":"Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo","volume":"29","author":"Charvin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib68","doi-asserted-by":"crossref","first-page":"12218","DOI":"10.1073\/pnas.0502698102","article-title":"Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation","volume":"102","author":"Charvin","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib69","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-8993(96)00307-1","article-title":"Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease","volume":"730","author":"Cicchetti","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib70","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/mds.870110605","article-title":"Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons","volume":"11","author":"Cicchetti","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib71","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/S0021-9258(18)50574-3","article-title":"Inactivation of succinate dehydrogenase by 3-nitropropionate","volume":"254","author":"Coles","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib72","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib73","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0304-3940(86)90397-6","article-title":"Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease","volume":"67","author":"Cross","year":"1986","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib74","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/01.wnl.0000238106.10423.00","article-title":"Effect of donepezil on motor and cognitive function in Huntington disease","volume":"67","author":"Cubo","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib75","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","article-title":"Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease","volume":"29","author":"Cummings","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib76","first-page":"57","article-title":"Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies","volume":"4","author":"Cummings","year":"2007","journal-title":"Rev Neurol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib77","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","article-title":"Mitochondria in Huntington's disease","volume":"1802","author":"Damiano","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib78","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)90921-7","article-title":"Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease","volume":"340","author":"Dawbarn","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.wnf.0000240945.44370.f0","article-title":"Two years' follow-up of rivastigmine treatment in Huntington disease","volume":"30","author":"de Tommaso","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib80","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/mds.20235","article-title":"Effects of rivastigmine on motor and cognitive impairment in Huntington's disease","volume":"19","author":"de Tommaso","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.coph.2006.08.010","article-title":"Plastic abnormalities in experimental Huntington's disease","volume":"7","author":"Di Filippo","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib83","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: a model for Huntington's disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib84","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib85","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","article-title":"Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-d-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease","volume":"57","author":"Dunah","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib85a","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ana.410300607","article-title":"Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease","volume":"30","author":"Dure","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib86","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease","volume":"27","author":"Fan","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib87","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","article-title":"Mouse models of Huntington's disease and methodological considerations for therapeutic trials","volume":"1792","author":"Ferrante","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib88","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","article-title":"Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease","volume":"411","author":"Ferrante","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib89","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1523\/JNEUROSCI.17-09-03052.1997","article-title":"Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum","volume":"17","author":"Ferrante","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib90","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease","volume":"46","author":"Ferrante","year":"1987","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib91","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","article-title":"Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization","volume":"119","author":"Ferrante","year":"1993","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib93","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1113\/jphysiol.2007.144501","article-title":"Cell-specific spike-timing-dependent plasticity in GABAergic and cholinergic interneurons in corticostriatal rat brain slices","volume":"586","author":"Fino","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib94","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.neuropharm.2011.01.023","article-title":"Spike-timing dependent plasticity in striatal interneurons","volume":"60","author":"Fino","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib95","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1523\/JNEUROSCI.14-02-00599.1994","article-title":"Input-output organization of the sensorimotor striatum in the squirrel monkey","volume":"14","author":"Flaherty","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib96","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease","volume":"19","author":"Fusco","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib97","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","article-title":"Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain","volume":"18","author":"Fusco","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib98","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ilar.50.2.128","article-title":"Large animal models of neurological disorders for gene therapy","volume":"50","author":"Gagliardi","year":"2009","journal-title":"Ilar J"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib99","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(91)90934-N","article-title":"Terminal excitability of the corticostriatal pathway","volume":"551","author":"Garcia-Munoz","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib100","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1523\/JNEUROSCI.5326-05.2006","article-title":"A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia","volume":"26","author":"Gardoni","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib101","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1523\/JNEUROSCI.07-12-03935.1987","article-title":"The neostriatal mosaic: III","volume":"7","author":"Gerfen","year":"1987","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib102","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/npp.2010.23","article-title":"TrkB\/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid","volume":"35","author":"Ghiglieri","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib103","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1460-9568.2005.04545.x","article-title":"Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease","volume":"23","author":"Giampa","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib104","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1460-9568.2009.06649.x","article-title":"Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6\/2 mouse model of Huntington's disease","volume":"29","author":"Giampa","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","article-title":"The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease","volume":"59","author":"Gil","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib106","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"Pt 3","key":"10.1016\/j.neuroscience.2011.06.075_bib107","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib108","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib109","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","article-title":"Loss of cannabinoid receptors in the substantia nigra in Huntington's disease","volume":"56","author":"Glass","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib110","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1523\/JNEUROSCI.23-17-06856.2003","article-title":"Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites","volume":"23","author":"Gorski","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib111","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ana.410280503","article-title":"A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease","volume":"28","author":"Grafton","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib112","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","article-title":"Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo","volume":"30","author":"Graham","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib113","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib114","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1126\/science.8091209","article-title":"The basal ganglia and adaptive motor control","volume":"265","author":"Graybiel","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib115","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1471-4159.1992.tb09431.x","article-title":"Quantitative autoradiography of dihydrorotenone binding to complex I of the electron transport chain","volume":"59","author":"Greenamyre","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib116","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.devbrainres.2004.12.012","article-title":"Area-specific effects of brain-derived neurotrophic factor (BDNF) genetic ablation on various neuronal subtypes of the mouse brain","volume":"156","author":"Grosse","year":"2005","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib117","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib118","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2004.11.008","article-title":"Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"48","author":"Hallett","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib119","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1523\/JNEUROSCI.0792-06.2006","article-title":"Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking","volume":"26","author":"Hallett","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-4886(90)90014-J","article-title":"A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon","volume":"108","author":"Hantraye","year":"1990","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib121","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib122","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington's disease","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.06.005","article-title":"Rodent genetic models of Huntington disease","volume":"32","author":"Heng","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib124","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","article-title":"Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease","volume":"27","author":"Heng","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib125","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1602\/neurorx.1.3.298","article-title":"Translating therapies for Huntington's disease from genetic animal models to clinical trials","volume":"1","author":"Hersch","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington's disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib127","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib128","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/brain\/awl332","article-title":"The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea","volume":"130","author":"Huot","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib129","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1523\/JNEUROSCI.5996-09.2010","article-title":"Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum","volume":"30","author":"Ibanez-Sandoval","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib130","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1523\/JNEUROSCI.3345-06.2007","article-title":"Brain-derived neurotrophic factor regulates the maturation of layer 4 fast-spiking cells after the second postnatal week in the developing barrel cortex","volume":"27","author":"Itami","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib131","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cne.902690207","article-title":"Cholinergic synaptic input to different parts of spiny striatonigral neurons in the rat","volume":"269","author":"Izzo","year":"1988","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib132","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington's disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib133","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease","volume":"29","author":"Joshi","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib134","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0166-2236(95)98374-8","article-title":"Striatal interneurones: chemical, physiological and morphological characterization","volume":"18","author":"Kawaguchi","year":"1995","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib135","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1471-4159.1987.tb05661.x","article-title":"Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum","volume":"48","author":"Kerkerian","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib136","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1073\/pnas.1032899100","article-title":"Impairment of reward-related learning by cholinergic cell ablation in the striatum","volume":"100","author":"Kitabatake","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib137","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington's disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib138","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1523\/JNEUROSCI.4232-04.2005","article-title":"Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis","volume":"25","author":"Kofalvi","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib139","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/8138","article-title":"Inhibitory control of neostriatal projection neurons by GABAergic interneurons","volume":"2","author":"Koos","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib141","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.neuroscience.2009.03.083","article-title":"In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid","volume":"161","author":"Kraft","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib142","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington's disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.physrep.2009.11.001","article-title":"Huntington's disease: pathogenesis to animal models","volume":"62","author":"Kumar","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib144","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.neuroscience.2007.03.036","article-title":"Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6\/2 mouse model of Huntington's disease","volume":"146","author":"Kung","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib145","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib146","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410370213","article-title":"Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals","volume":"37","author":"Landwehrmeyer","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib147","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0306-4522(92)90293-B","article-title":"Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat","volume":"51","author":"Lapper","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib148","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(01)03403-5","article-title":"Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease","volume":"929","author":"Lastres-Becker","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib149","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/00001756-200107200-00017","article-title":"Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease","volume":"12","author":"Lastres-Becker","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0092-8674(02)00962-5","article-title":"Dual regulation of NMDA receptor functions by direct protein\u2013protein interactions with the dopamine D1 receptor","volume":"111","author":"Lee","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib151","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib152","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/hmg\/ddg218","article-title":"Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release","volume":"12","author":"Li","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib153","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib154","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib155","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib156","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib157","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1523\/JNEUROSCI.5027-04.2005","article-title":"Feedforward inhibition of projection neurons by fast-spiking GABA interneurons in the rat striatum in vivo","volume":"25","author":"Mallet","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib158","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib159","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0896-6273(00)80075-6","article-title":"GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor","volume":"16","author":"Marty","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neures.2008.08.007","article-title":"The fate of the large striatal interneurons expressing calretinin in Huntington's disease","volume":"62","author":"Massouh","year":"2008","journal-title":"Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib161","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198702123160701","article-title":"Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease","volume":"316","author":"Mazziotta","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib162","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib163","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-4328(97)86042-1","article-title":"Interaction of neuromodulatory systems in modulating memory storage","volume":"83","author":"McGaugh","year":"1997","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib164","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0006-8993(87)90855-9","article-title":"The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain","volume":"423","author":"McGeorge","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0306-4522(89)90128-0","article-title":"The organization of the projection from the cerebral cortex to the striatum in the rat","volume":"29","author":"McGeorge","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib166","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib167","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","article-title":"Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease","volume":"162","author":"Menalled","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib168","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","article-title":"Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice","volume":"22","author":"Menalled","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib169","first-page":"125","article-title":"Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions","volume":"7","author":"Menegoz","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2009.09.013","article-title":"Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease","volume":"37","author":"Miller","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib171","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1152\/jn.90606.2008","article-title":"Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease","volume":"100","author":"Miller","year":"2008","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib172","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","article-title":"Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease","volume":"15","author":"Milnerwood","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib173","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib174","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1113\/jphysiol.2007.142448","article-title":"Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load","volume":"585","author":"Milnerwood","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib175","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib176","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib177","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.neuroscience.2003.08.053","article-title":"Molecular and behavioral analysis of the R6\/1 Huntington's disease transgenic mouse","volume":"122","author":"Naver","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib178","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0031-6865(99)00047-3","article-title":"Nicotinic systems in central nervous systems disease: degenerative disorders and beyond","volume":"74","author":"Newhouse","year":"2000","journal-title":"Pharm Acta Helv"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib179","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.0953-816X.2000.01379.x","article-title":"Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6\/1 Huntington transgenic mice","volume":"13","author":"Nicniocaill","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib180","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1523\/JNEUROSCI.3481-09.2010","article-title":"Cell type-specific long-term plasticity at glutamatergic synapses onto hippocampal interneurons expressing either parvalbumin or CB1 cannabinoid receptor","volume":"30","author":"Nissen","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib181","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice","volume":"29","author":"Nithianantharajah","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib182","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1101\/lm.1.2.129","article-title":"Low-frequency stimulation erases LTP through an NMDA receptor-mediated activation of protein phosphatases","volume":"1","author":"O'Dell","year":"1994","journal-title":"Learn Mem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib183","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/jnnp.2009.171926","article-title":"Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease","volume":"81","author":"Orth","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib184","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1523\/JNEUROSCI.2149-10.2010","article-title":"Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition","volume":"30","author":"Paille","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib185","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1523\/JNEUROSCI.3709-06.2007","article-title":"Cholinergic interneurons control the excitatory input to the striatum","volume":"27","author":"Pakhotin","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib186","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib187","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington's disease decades before diagnosis: the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib188","doi-asserted-by":"crossref","first-page":"12831","DOI":"10.1523\/JNEUROSCI.3177-09.2009","article-title":"Corticostriatal interactions during learning, memory processing, and decision making","volume":"29","author":"Pennartz","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib189","first-page":"1217","article-title":"Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease","volume":"21","author":"Perez-Navarro","year":"2006","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/exnr.2002.7885","article-title":"Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease","volume":"175","author":"Petersen","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib191","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/nbdi.2002.0534","article-title":"Evidence for dysfunction of the nigrostriatal pathway in the R6\/1 line of transgenic Huntington's disease mice","volume":"11","author":"Petersen","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib192","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib193","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nbd.2005.10.009","article-title":"Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons","volume":"22","author":"Picconi","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib194","doi-asserted-by":"crossref","first-page":"RC69","DOI":"10.1523\/JNEUROSCI.20-07-j0003.2000","article-title":"Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons","volume":"20","author":"Pisani","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0278-5846(00)00153-6","article-title":"Role of tonically-active neurons in the control of striatal function: cellular mechanisms and behavioral correlates","volume":"25","author":"Pisani","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib196","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(00)02437-5","article-title":"New dopaminergic neurons in Parkinson's disease striatum","volume":"356","author":"Porritt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib197","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11302-007-9066-y","article-title":"Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington's disease","volume":"3","author":"Potenza","year":"2007","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib198","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1523\/JNEUROSCI.22-18-08158.2002","article-title":"Synaptic convergence of motor and somatosensory cortical afferents onto GABAergic interneurons in the rat striatum","volume":"22","author":"Ramanathan","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib199","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib200","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/2510","article-title":"Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA","volume":"20","author":"Reddy","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib201","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib202","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1523\/JNEUROSCI.18-23-10116.1998","article-title":"Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease","volume":"18","author":"Reynolds","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(90)90501-Y","article-title":"Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not the cerebral cortex","volume":"113","author":"Reynolds","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib204","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(91)90448-3","article-title":"Heterogeneous dopamine receptor changes in early and late Huntington's disease","volume":"132","author":"Richfield","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib206","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/exnr.1993.1197","article-title":"Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome","volume":"124","author":"Roberts","year":"1993","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib207","first-page":"137","article-title":"Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease","volume":"50","author":"Roitberg","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib208","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1468-1331.2002.00447_4.x","article-title":"Rivastigmine in the treatment of Huntington's disease","volume":"9","author":"Rot","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib209","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(00)80563-2","article-title":"BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses","volume":"21","author":"Rutherford","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-4886(89)90170-2","article-title":"The quinolinic acid model of Huntington's disease: locomotor abnormalities","volume":"105","author":"Sanberg","year":"1989","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib211","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005072-199902000-00006","article-title":"Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease","volume":"58","author":"Sapp","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib212","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib213","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.biopsych.2008.12.026","article-title":"Abnormal motor cortex excitability in preclinical and very early Huntington's disease","volume":"65","author":"Schippling","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib214","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/jcbfm.1994.134","article-title":"3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum","volume":"14","author":"Schulz","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-8993(77)90538-8","article-title":"Striatal lesions with kainic acid: neurochemical characteristics","volume":"127","author":"Schwarcz","year":"1977","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib216","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1523\/JNEUROSCI.20-01-00219.2000","article-title":"Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain","volume":"20","author":"Senut","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib217","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","article-title":"A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice","volume":"8","author":"Shelbourne","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib218","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1160575","article-title":"Dichotomous dopaminergic control of striatal synaptic plasticity","volume":"321","author":"Shen","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib219","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1523\/JNEUROSCI.1449-04.2004","article-title":"On the activity of the corticostriatal networks during spike-and-wave discharges in a genetic model of absence epilepsy","volume":"24","author":"Slaght","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib220","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib221","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/hmg\/ddl252","article-title":"Cholinergic neuronal defect without cell loss in Huntington's disease","volume":"15","author":"Smith","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib222","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","article-title":"Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease","volume":"157","author":"Spampanato","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib223","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/103.1.179","article-title":"Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue","volume":"103","author":"Spokes","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib224","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0022-510X(80)90103-3","article-title":"Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects","volume":"48","author":"Spokes","year":"1980","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib225","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1523\/JNEUROSCI.4318-07.2007","article-title":"Neuroprotective effects of synaptic modulation in Huntington's disease R6\/2 mice","volume":"27","author":"Stack","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib226","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/j.1471-4159.1992.tb10080.x","article-title":"1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism","volume":"58","author":"Storey","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib227","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng1193-259","article-title":"Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues","volume":"5","author":"Strong","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib228","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.expneurol.2003.08.016","article-title":"Enkephalinergic striatal projection neurons become less affected by quinolinic acid than substance P-containing striatal projection neurons as rats age","volume":"184","author":"Sun","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib229","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/syn.1089","article-title":"Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers","volume":"41","author":"Suzuki","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib230","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0306-4522(97)00597-6","article-title":"Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum","volume":"85","author":"Szabo","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib231","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington's disease","volume":"27","author":"Tang","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib232","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib233","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1100\/tsw.2010.164","article-title":"Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington's disease","volume":"10","author":"Tebano","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib234","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnana.2010.00150","article-title":"Heterogeneity and diversity of striatal GABAergic interneurons","volume":"4","author":"Tepper","year":"2010","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib235","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib236","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1098-2396(20000915)37:4<252::AID-SYN2>3.0.CO;2-A","article-title":"Cortical inputs to m2-immunoreactive striatal interneurons in rat and monkey","volume":"37","author":"Thomas","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib237","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0962-8924(00)01853-5","article-title":"Huntington's disease: the challenge for cell biologists","volume":"10","author":"Tobin","year":"2000","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib238","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1523\/JNEUROSCI.4082-10.2011","article-title":"The distinct role of medium spiny neurons and cholinergic interneurons in the D2\/A2A receptor interaction in the striatum: implications for Parkinson's disease","volume":"31","author":"Tozzi","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib239","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.neuropharm.2007.08.006","article-title":"Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission","volume":"53","author":"Tozzi","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib240","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1139\/o06-181","article-title":"Hypothesis: huntingtin may function in membrane association and vesicular trafficking","volume":"84","author":"Truant","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib241","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","article-title":"Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease","volume":"97","author":"Turmaine","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib242","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1523\/JNEUROSCI.0448-07.2007","article-title":"Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum","volume":"27","author":"Uchigashima","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib243","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/00001756-199607290-00020","article-title":"Dopaminergic denervation of striatum results in elevated expression of NR2A subunit","volume":"7","author":"Ulas","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib244","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","article-title":"Impaired synaptic plasticity in mice carrying the Huntington's disease mutation","volume":"8","author":"Usdin","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib245","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib246","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2008.02390.x","article-title":"Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease","volume":"16","author":"van Oostrom","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib247","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0959-4388(03)00073-4","article-title":"Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation","volume":"13","author":"Vanhoutte","year":"2003","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib248","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1471-4159.2003.01704.x","article-title":"Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum","volume":"85","author":"Vetter","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib249","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib250","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/exnr.1994.1081","article-title":"Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease","volume":"127","author":"Wagster","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib251","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1523\/JNEUROSCI.2804-08.2008","article-title":"Altered information processing in the prefrontal cortex of Huntington's disease mouse models","volume":"28","author":"Walker","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib252","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","article-title":"Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease","volume":"17","author":"Wang","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib253","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1745-7254.2006.00410.x","article-title":"Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib254","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.neuron.2006.04.010","article-title":"Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons","volume":"50","author":"Wang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","article-title":"Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse","volume":"8","author":"Wheeler","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib256","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib257","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng1297-404","article-title":"Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion","volume":"17","author":"White","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib258","doi-asserted-by":"crossref","first-page":"377","DOI":"10.55782\/ane-1994-1044","article-title":"Cholinergic manipulations and passive avoidance in the rat: effects on acquisition and recall","volume":"54","author":"Wilson","year":"1994","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib259","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0006-8993(00)02135-1","article-title":"Striatal interneurons expressing calretinin, parvalbumin or NADPH-diaphorase: a comparative study in the rat, monkey and human","volume":"863","author":"Wu","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib260","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1523\/JNEUROSCI.22-17-07580.2002","article-title":"Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons","volume":"22","author":"Yamada","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib261","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib262","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/7854_2010_105","article-title":"Transgenic animal models of Huntington's disease","volume":"7","author":"Yang","year":"2011","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib263","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington's disease in a non-human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib264","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","article-title":"NMDA receptor losses in putamen from patients with Huntington's disease","volume":"241","author":"Young","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nbd.2008.03.010","article-title":"Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease","volume":"31","author":"Zhang","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib266","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib267","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.06.075_bib268","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat Genet"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211007858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211007858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T01:58:36Z","timestamp":1741312716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452211007858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":270,"alternative-id":["S0306452211007858"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2011.06.075","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}